Streetbeat News

Products Services

AVD

American Vanguard Corporation (NYSE:AVD) has submitted voluntary cancellation requests to the EPA for all federal registrations of its Dacthal herbicide products. This follows an emergency suspension by the EPA and the company's decision to stop sales in April 2024.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 1:06 pm

MULN

Bollinger Motors, a subsidiary of Mullen Automotive, is set to begin production of saleable units of the Bollinger B4 Chassis Cab on September 16. This marks a significant milestone for Mullen as it expands its electric vehicle offerings.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 1:05 pm

CBOE

TLT

CBOE Global Markets has introduced the VIXTLT Index, a new volatility index focused on the U.S. Treasury market, particularly targeting bonds with maturities over 20 years. This index, which uses the iShares 20+ Year Treasury Bond ETF (TLT) as a reference, measures volatility in basis points, offering insights into bond market movements. The VIXTLT complements the VIX, which tracks equity market volatility, providing a broader view of market sentiment.

Portfolio Pulse from Surbhi Jain

August 21, 2024 | 1:04 pm

DGX

Quest Diagnostics is set to acquire University Hospitals' outreach laboratory services business, expanding its diagnostic services in Ohio. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 1:03 pm

META

Meta Platforms is aiming to become a leader in artificial intelligence by promoting its large language model, Llama 3, as an industry standard. CEO Mark Zuckerberg is focusing on pitching this AI software to big businesses, a new venture for the company.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 1:03 pm

SCLX

Scilex Holding Company announced that the USPTO will issue a new patent for ELYXYB, a treatment for acute pain. This development could enhance Scilex's intellectual property portfolio and potentially boost its market position.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 1:02 pm

LLY

NVO

Novo Nordisk and Eli Lilly are competing in the obesity-drug market, but their strategic expansions into other healthcare sectors could drive long-term growth. Eli Lilly has overcome supply chain challenges, while Novo Nordisk faces difficulties. Both stocks show bullish trends, with Eli Lilly technically stronger.

Portfolio Pulse from Surbhi Jain

August 21, 2024 | 12:51 pm

SNOA

Sonoma Pharmaceuticals has entered into a distribution agreement with a leading global healthcare distributor to market and distribute its wound care products in the U.S. This partnership will leverage an extensive network of hospital systems and healthcare channels.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:48 pm

OGEN

Oragenics shares rose following the completion of the filing for its ONP-002 drug, which is set to enter Phase IIa clinical trials for concussed patients.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:48 pm